Pharma Knowledge Layer · Global Orphan Drug Access Intelligence
OrphanDrug
OrphanDrug
Pharma Knowledge Base
DrugsDiseasesCountriesPathwaysProgramsSuppliersAPI Docs

Navigation

DrugsDiseasesCountriesPathwaysProgramsSuppliersAPI Docs

About

OrphanDrug covers global rare drug access intelligence for 193 countries.

HomeAccess Programs

Access Programs

5 programs
Clear
AllNamed PatientCompassionate UseEarly AccessExpanded AccessSpecial Access
Indonesia Special Access Scheme
Framework: Government Regulation No. 72/1998
Patient with serious or life-threatening condition, no registered alternative available
Special Access30d
Malaysia Special Access Scheme
Framework: Malaysian Drug Control Authority Act 1984
Patient with serious or life-threatening condition, no registered alternative available
Special Access14d
Singapore Special Access Route
Framework: Health Products Act
Patient with serious or life-threatening condition, no registered alternative available
Special Access7d
Special Access Program – Canada
Framework: Food and Drug Regulations C.08.010
Patient with serious or life-threatening condition, no registered alternative available
Special Access5d
TGA Special Access Scheme – Australia
Framework: Therapeutic Goods Act 1989
Patient with serious or life-threatening condition, no registered alternative available
Special Access28d
OrphanDrug — Global Pharma Knowledge Base
DrugsDiseasesCountriesPathwaysProgramsSuppliersAPI Docs|Terms of UsePrivacy Policy